Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)

AbbVie · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
cancer
small cell lung cancer, extensive-stage small cell lung cancer (ed sclc), cancer, platinum-based chemotherapy, rovalpituzumab tesirine, first-line chemotherapy, small cell lung cancer (sclc), delta-like protein 3 (dll3), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 860117
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.